韶鋼松山(000717.SZ):控股股東更名為“寶武集團中南鋼鐵有限公司”
格隆匯11月20日丨韶鋼松山(000717.SZ)公佈,公司於近日收到控股股東寶武集團廣東韶關鋼鐵有限公司的通知,經廣東省市場監督管理局核准,該公司名稱由“寶武集團廣東韶關鋼鐵有限公司”變更為“寶武集團中南鋼鐵有限公司”,住址由“廣州市荔灣區西村西增路內協和路10號”變更為“廣東省廣州市海珠區琶洲大道83號302室”,並已完成公司變更登記手續,取得了新的《營業執照》。控股股東該次除公司名稱和住所變更外,其他公司登記事項未發生變更。
該次變更後,寶武集團中南鋼鐵有限公司持有的公司股份總數和持股比例不變,仍為公司控股股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.